TETRALOGIC PHARMACEUTICALS C - COM (TLOG)

CUSIP: 88165U109

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
658,992
Share change
-196,500
Total reported value
$204,000
Price per share
$0.32
Number of holders
17
Value change
-$36,791
Number of buys
4
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 88165U109?
CUSIP 88165U109 identifies TLOG - TETRALOGIC PHARMACEUTICALS C - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRALOGIC PHARMACEUTICALS C - COM (TLOG) as of Q2 2016

As of 30 Jun 2016, TETRALOGIC PHARMACEUTICALS C - COM (TLOG) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 658,992 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, HighTower Advisors, LLC, GUGGENHEIM CAPITAL LLC, NORTHERN TRUST CORP, and Creative Planning. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.